Manufacturer record
Syndicate Pharma: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
6 batches manufactured by Syndicate Pharma (Madhya Pradesh) were declared Not of Standard Quality between December 2024 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: B82, Betamethasone Valerate Ointment IP 0.1% w/w (exp Jul 2026). CDTL Chennai (CDSCO lab) found it not of standard quality: Content of Betamethasone in Betamethasone Valerate. Listed in the June 2025 alert.
Records by type
6 records linked to Syndicate Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Betamethasone Valerate Ointment IP 0.1% w/w | Batch B82Mfg Aug 2024 · Exp Jul 2026 | Content of Betamethasone in Betamethasone ValerateOther | CDTL ChennaiCDSCO lab | Jun 2025 |
| Betamethasone Valerate Ointment IP 0.1% w/w | Batch B73Mfg Aug 2024 · Exp Jul 2026 | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | Drugs Testing Laboratory, Chennai-06State lab | May 2025 |
| Betamethasone Valerate Ointment IP 0.1% w/w | Batch B75Mfg Aug 2024 · Exp Jul 2026 | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone ValerateOther | DTL MaduraiState lab | Apr 2025 |
| Betamethas one Valerate Ointment IP 0.1% w/w | Batch B76Mfg Aug 2024 · Exp Jul 2026 | Sample does not conform to IP Specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL ChennaiState lab | Jan 2025 |
| Betamethas one Valerate Oilment IP 0.1% w/w | Batch BO6Mfg May 2024 · Exp Apr 2026 | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL ChennaiState lab | Jan 2025 |
| Betamethasone Valerate Ointment IP 01% w/w | Batch B06Mfg May 2024 · Exp Apr 2026 | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate.Other | DTL MaduraiState lab | Dec 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.